Meningococcal-Polysaccharide-Group-A shortage status
No active shortage currently reported by the regulators Mederti tracks — 1 anticipated notice on file.
Last updated 30 Oct 2026 · sourced from official medicines regulators
- Generic name (INN)
- Meningococcal-Polysaccharide-Group-A
- Brand names
- C, W-135, NIMENRIX meningococcal (Groups A, Y) polysaccharide tetanus toxoid conjugate vaccine injection vial and diluent syringe
- Class
- Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper
Recent shortage history
- Australia: resolved 26 Oct 2026 (began 26 Oct 2026)
- Australia: resolved 26 Jun 2026 (began 8 Jun 2026)
Frequently asked questions
Is Meningococcal-Polysaccharide-Group-A currently in shortage?
No active shortage of Meningococcal-Polysaccharide-Group-A is currently reported by any of the national medicines regulators Mederti tracks. Shortages can emerge quickly — this page updates daily from official sources.
Where does this Meningococcal-Polysaccharide-Group-A shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Get alerted when Meningococcal-Polysaccharide-Group-A status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.